Approach to Neonates and Young Infants with Fever without a Source Who Are at Risk for Severe Bacterial Infection

Susanna Esposito1, Victoria Elisa Rinaldi1, Alberto Argentiero1

  • 1Pediatric Clinic, Department of Surgical and Biomedical Sciences, Università degli Studi di Perugia, Perugia, Italy.

Mediators of Inflammation
|December 25, 2018
PubMed

Insights

Identifying serious bacterial infections (SBIs) in infants with fever without source (FWS) remains challenging. Newer criteria and biomarkers like C-reactive protein (CRP) and procalcitonin (PCT) improve risk stratification, but careful antibiotic selection is crucial.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Neonatology

Background:

  • Fever without source (FWS) in neonates and infants under 3 months presents a diagnostic challenge, with 5-15% having serious bacterial infections (SBIs).
  • Existing algorithms aim to differentiate low-risk from high-risk infants, guiding clinical management.
  • This review synthesizes current knowledge on FWS management in young infants.

Purpose of the Study:

  • To describe the current management strategies for fever without source in young infants.
  • To discuss the impact of recent findings on clinical practice for managing FWS.

Main Methods:

  • A comprehensive literature search was conducted using PubMed.
  • Keywords included "fever without source," "fever of unknown origin," "meningitis," "sepsis," "urinary tract infection," and terms related to neonates and infants under 3 months.
  • Studies published over the last 35 years were included.

Main Results:

  • The Rochester criteria are effective for identifying young infants (29-60 days) without SBIs.
  • Biomarkers such as C-reactive protein (CRP) and procalcitonin (PCT) enhance the identification of infants with SBIs.
  • Evaluating neonates (<29 days) is complex due to their persistent high risk of SBIs, including bacteremia and meningitis.

Conclusions:

  • Accurate risk stratification for SBIs in infants with FWS remains an ongoing challenge.
  • While established criteria exist, laboratory markers significantly improve diagnostic accuracy.
  • Optimal antibiotic selection requires consideration of clinical presentation, laboratory data, evolving epidemiology, and antibiotic resistance patterns.
Abstract

Related Concept Videos

Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
13.5K
Types of Fever01:25

Types of Fever

Fever can be triggered by several factors, including infections, nervous system disorders, certain cancers, blood diseases like leukemia, embolism, thrombosis, heatstroke, dehydration, surgical trauma, crushing injuries, and allergic reactions.
Here are the different types of fever:
1.2K
Patterns of Fever01:26

Patterns of Fever

Before understanding the types and patterns of fever, it is essential to know its phases.
3.9K
Methods of reducing fever01:22

Methods of reducing fever

The signs and symptoms of fever include hot and dry skin, flushed face, thirst, muscle aches, anorexia, headache, tachycardia, tachypnea, and fatigue. Elevated body temperature is reduced using two methods: pharmacological and nonpharmacological. Proper identification and treatment of the root cause of a fever is of utmost importance.
Pharmacological Methods of Reducing Fever:
1.4K
Relative Risk01:12

Relative Risk

Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
2.1K
Bacterial Transformation01:33

Bacterial Transformation

In 1928, bacteriologist Frederick Griffith worked on a vaccine for pneumonia, which is caused by Streptococcus pneumoniae bacteria. Griffith studied two pneumonia strains in mice: one pathogenic and one non-pathogenic. Only the pathogenic strain killed host mice.
Griffith made an unexpected discovery when he killed the pathogenic strain and mixed its remains with the live, non-pathogenic strain. Not only did the mixture kill host mice, but it also contained living pathogenic bacteria that...
59.9K